Dong-A ST signed a joint sales agreement with Ibsen Korea on the 30th for the treatment of precocious puberty and prostate ...

Phase II, open-label, randomized study of first-line zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in Claudin 18.2–positive metastatic pancreatic cancer (mPC). Authors : Wungki Park , Eileen ...